ReviewESMO open2017

Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets.

Pedro Nazareth Aguiar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.